‘Walking with’: a walk in the most hopeful stage of multiple myeloma
The article discusses a project called ‘Caminando con’ that promotes hope and connection between multiple myeloma patients and their healthcare providers through shared experiences in rural Spain.
The article highlights a project titled ‘Caminando con,’ initiated by Johnson & Johnson, which aims to bring together multiple myeloma patients and their hematologists in a personal and enriching way. The story follows Óscar, a rancher from a small village in Ávila, who invites his hematologist to visit his homeland, where they stroll through cork oak forests, share memories over coffee, and even operate a tractor together. This initiative emphasizes the importance of personal connection and understanding in the management of chronic illnesses, showcasing how life continues even when facing challenging health conditions.
Multiple myeloma, a type of cancer that affects the bone marrow and plasma cells, is the second most common hematological cancer, with over 3,000 diagnoses per year in Spain alone. The average age of diagnosis ranges from 66 to 70 years, yet a significant number of patients are under 65, underscoring the impact of this disease on individuals who are still actively engaged in their professional and family lives. This raises important conversations around the ways in which healthcare approaches can be humanized, fostering better relationships between patients and doctors.
The project not only provides comfort and hope to patients but also serves as a platform for acknowledging the emotional and psychological aspects of living with an incurable disease. By framing the conversation around experiences, relationships, and community, ‘Caminando con’ looks to redefine the patient-doctor dynamic and encourages an exploration of life beyond medical treatments, highlighting resilience and the ongoing journey of wellness, despite the challenges of multiple myeloma.